ClariVest Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $337 | Hold |
42
| – | – | ﹤0.01% | 826 |
|
|
2024
Q2 | $337 | Sell |
42
-122
| -74% | -$979 | ﹤0.01% | 826 |
|
|
2024
Q1 | $2.43K | Buy |
164
+42
| +34% | +$622 | ﹤0.01% | 546 |
|
|
2023
Q4 | $992 | Hold |
122
| – | – | ﹤0.01% | 659 |
|
|
2023
Q3 | $0 | Sell |
122
-95
| -44% | – | ﹤0.01% | 807 |
|
|
2023
Q2 | $1K | Buy |
217
+52
| +32% | +$240 | ﹤0.01% | 611 |
|
|
2023
Q1 | $1K | Hold |
165
| – | – | ﹤0.01% | 663 |
|
|
2022
Q4 | $1K | Hold |
165
| – | – | ﹤0.01% | 631 |
|
|
2022
Q3 | $2K | Buy |
+165
| New | +$2K | ﹤0.01% | 535 |
|
|
2021
Q2 | – | Sell |
-9
| Closed | – | – | 791 |
|
|
2021
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 769 |
|
|
2020
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 786 |
|
|
2020
Q3 | $0 | Sell |
9
-43,871
| -100% | – | ﹤0.01% | 803 |
|
|
2020
Q2 | $1.2M | Buy |
43,880
+7,067
| +19% | +$194K | 0.03% | 301 |
|
|
2020
Q1 | $1.1M | Buy |
+36,813
| New | +$1.1M | 0.03% | 283 |
|